Variable effects of transgenic c-Maf on autoimmune diabetes

Diabetes

Volumn 50, Issue 1, 2001, Pages 39-46

  Pauza, Mary E ^a,e   Nguyen, Andrea ^a   Wolfe, Tom ^a   Ho, I Cheng ^c   Glimcher, Laurie H ^c,d   Von Herrath, Matthias ^a   Lo, David ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Digital Gene Technologies Inc   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GENE PRODUCT; HEMAGGLUTININ; INTERLEUKIN 4; NUCLEOPROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR C MAF; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL POLARITY; CONTROLLED STUDY; DIABETES MELLITUS; HELPER CELL; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH2 CELL; TRANSGENIC MOUSE; VIRUS INFECTION; VIRUS MENINGITIS;

EID: 0035156871     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.1.39     Document Type: Article

References (44)

1. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates: Requirement for both L3T4+ and Lyt2+ T-cells
2. Immunotherapy of the nonobese diabetic mouse: Treatment with an antibody to T-helper lymphocytes
3. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes
4. Major histocompatibility complex class I-deficient NOD-B2m null mice are diabetes and insulitis resistant
5. The role of CD4 vs. CD8 T-cell in IDDM
6. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of antiself (virus) immune response
7. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model
8. On the various manifestations of spontaneous autoimmune diabetes in rodent models
9. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice
10. CD8(+) T-cell-mediated spontaneous diabetes in neonatal mice
11. The murine autoimmune diabetes model: NOD and related strains
12. Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes
13. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity
14. Coexpression of B7-1 and viral ("self") transgenes in pancreatic β-cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes
15. Type I diabetes: A chronic autoimmune disease of human, mouse, and rat
16. Natural history of IDDM
17. + Th1 and Th2 cells derived from the spleens of diabetic NOD mice
18. + T-cells in the pathogenesis of organ-specific autoimmune diseases
19. T helper cell subsets in insulin-dependent diabetes
20. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice
21. T helper 2 (Th2) T-cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice
22. Deviation of pancreas-infiltrating cells to Th2 by interleukin- 12 antagonist administration inhibits autoimmune diabetes
23. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes 1
24. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis
25. Interleukin-13 prevents autoimmune diabetes in NOD mice
26. + regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells
27. + T-cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway
28. T-cell production of an inducible interleukin-10 transgene provides limited protection from autoimmune diabetes
29. Disruption of the murine IL-4 gene blocks Th2 cytokine responses
30. Generation and analysis of interleukin-4 deficient mice
31. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
32. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function
33. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4
34. c-maf promotes T helper cell type 2 (Tb2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms
35. The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines
36. + T cells
37. Thymic tolerance to only one viral protein reduces lymphocytic choriomeningitis virus-induced immunopathology and increases survival in perforin-deficient mice
38. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection
39. Interferon-gamma is essential for destruction of β cells and development of insulin-dependent diabetes mellitus
40. Comparative genetics of type 1 diabetes and autoimmune disease: Common loci, common pathways?
41. Genetic control of autoimmune diabetes in the NOD mouse
42. Genetic control of diabetes progression
43. Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice
44. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection